• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Drug Resist . Clinical Characteristics and Prognostic Factors of Severe COVID-19

tetano

Editor, Senior Moderator
Infect Drug Resist


. 2025 Jun 25:18:3117-3125.
doi: 10.2147/IDR.S525970. eCollection 2025. Clinical Characteristics and Prognostic Factors of Severe COVID-19

Yun Yang[SUP] #[/SUP][SUP] 1 [/SUP], Ziyi Huang[SUP] #[/SUP][SUP] 1 [/SUP], Yongjian Pei[SUP] 1 [/SUP], Yongkang Huang[SUP] 1 [/SUP], Chen Chen[SUP] 1 [/SUP], Tong Zhou[SUP] 1 [/SUP]



Affiliations
Abstract

Purpose: Coronavirus disease-2019 (COVID-19) has high mortality and has caused heavy economic burden worldwide. In this study, we investigated the clinical characteristic and prognostic factors of patients with severe COVID-19. We aimed to identify the severe cases in early stages to improve the prognosis and mortality.
Patients and methods: We collected the clinical data of 98 patients with severe COVID-19, who were admitted to the Second Affiliated Hospital of Soochow University (Jiangsu, China) from December 2022 to November 2023. The patients were divided into two groups, namely survivors and non-survivors, based on the outcomes of hospitalization. The risk factors affecting the prognosis of severe COVID-19 patients were identified by univariate analysis and multivariate logistic regression analysis. The predictive value of the individual and combined risk factors for the prognosis of severe COVID-19 was evaluated by the area under the receiver operating characteristic curve (AUROC).
Results: Compared with survivors, non-survivors had higher white blood cell (WBC) count, neutrophil count, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and platelet (PLT) count. Moreover, non-survivors exhibited a higher propensity to develop acute kidney injury (AKI) and receive mechanical ventilation (MV) and continuous renal replacement therapy (CRRT). Multivariate logistic regression analysis showed that WBC count, PLT count, APACHE II score, and MV were independent risk factors affecting the prognosis of severe COVID-19 patients, with AUC values of 0.807, 0.690, 0.761, and 0.751, respectively. The AUC of the combined risk factors was 0.897.
Conclusion: WBC count, PLT count, APACHE II score, and MV were independent risk factors for the poor prognosis of severe COVID-19 patients. High WBC count, PLT count, and APACHE II score, as well as the use of MV, showed good predictive value for the mortality of severe COVID-19 cases, especially when combined.

Keywords: APACHE II score; COVID-19; mechanical ventilation; platelet count; white blood cell.

 
Back
Top Bottom